“Radiolabeled Peptide As Diagnostic, Therapeutic, and Theranostic Agents for Prostate Cancer: Systematic Literature Review”. 2022. Pharmaceutical Reports 1 (1). https://doi.org/10.33096/pharmrep.v1i1.174.